Felice Gragnano

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

Pasquale Paolisso, Luca Bergamaschi, Gaetano Santulli et al. · Cardiovascular Diabetology · 2022 · 204 citations · Full text

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Yasushi Ueki, Sarah Bär, Sylvain Losdat et al. · EuroIntervention · 2020 · 194 citations

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

Pasquale Paolisso, Luca Bergamaschi, Felice Gragnano et al. · Pharmacological Research · 2022 · 140 citations · Full text

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk

Noé Corpataux, Alessandro Spirito, Felice Gragnano et al. · European Heart Journal · 2020 · 132 citations · Full text